3B BlackBio Dx Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 04:59 pm
13-11-2025 | 04:59 pm
3B BlackBio Dx's board approved Q2 & H1 FY26 financials. Consolidated Q2 revenue: ₹33.9 Cr, profit: ₹15.04 Cr. H1 revenue: ₹56.74 Cr, profit: ₹27.68 Cr. Figures incorporate Coris Holding SRL acquisition from late Aug. Agrochemicals are seasonal.
No comments yet. Be the first to comment!
